History of haematopoietic stem-cell transplantation

[1]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[2]  P. Huie,et al.  Predominance of NK1.1+TCRαβ+ or DX5+TCRαβ+ T Cells in Mice Conditioned with Fractionated Lymphoid Irradiation Protects Against Graft-Versus-Host Disease: “Natural Suppressor” Cells1 , 2001, The Journal of Immunology.

[3]  C. Hillyer.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives In patients with hematologic cancers , 2001 .

[4]  R. Noelle,et al.  Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade , 2001, The Journal of experimental medicine.

[5]  J. Radich,et al.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.

[6]  F. Appelbaum,et al.  Haematopoietic cell transplantation as immunotherapy , 2001, Nature.

[7]  C. Flowers,et al.  Nonmyeloablative Hematopoietic Cell Transplantation , 2001, Current opinion in oncology.

[8]  R Storb,et al.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.

[9]  C. Flowers,et al.  Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. , 2001, Annals of the New York Academy of Sciences.

[10]  R. Gress,et al.  Th2 and Tc2 Cells in the Regulation of GVHD, GVL, and Graft Rejection: Considerations for the Allogeneic Transplantation Therapy of Leukemia and Lymphoma , 2000, Leukemia & lymphoma.

[11]  G. Duclos.  New York 1987 , 2000 .

[12]  E. Thomas,et al.  Historical markers in the development of allogeneic hematopoietic cell transplantation. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. , 1999, Blood.

[14]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. , 1999, Blood.

[15]  A. Tosti,et al.  Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.

[16]  M. Martelli,et al.  Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Verdijk,et al.  Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. , 1999, Blood.

[18]  M. Gavin,et al.  Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. , 1998, Current opinion in hematology.

[19]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[20]  A. Nademanee,et al.  Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. , 1998, Blood.

[21]  N. Ueno,et al.  Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Warren,et al.  Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. , 1998, Blood.

[23]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[24]  S. Mackinnon,et al.  T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. , 1998, Blood.

[25]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[26]  E. Estey,et al.  Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. , 1997, Blood.

[27]  E. Goulmy.  Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy , 1997, Immunological reviews.

[28]  R. Storb,et al.  Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene. , 1997, Tissue antigens.

[29]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.

[30]  L. Brent.  A history of transplantation immunology , 1996 .

[31]  R. Storb,et al.  Molecular analysis of DLA-DRBB1 polymorphism. , 1996, Tissue antigens.

[32]  R. Champlin,et al.  Peripheral Blood Progenitor Cell Transplantation: A Replacement for Marrow Auto‐ or Allografts , 1996, Stem cells.

[33]  N. Schmitz,et al.  Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients , 1996, The Lancet.

[34]  R. Storb,et al.  Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony Stimulating Factor , 1996, Stem cells.

[35]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[37]  S. Mackinnon,et al.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.

[38]  A. van Leeuwen,et al.  Bone Marrow Donors Worldwide: a successful exercise in international cooperation. , 1994, Bone marrow transplantation.

[39]  H. Deeg,et al.  FK‐506 AND METHOTREXATE PREVENT GRAFT‐VERSUS-HOST DISEASE IN DOGS GIVEN 9.2 Gy TOTAL BODY IRRADIATION AND MARROW GRAFTS FROM UNRELATED DOG LEUKOCYTE ANTIGEN‐NONIDENTICAL DONORS , 1993, Transplantation.

[40]  G. Snell,et al.  The Nobel Lectures in Immunology. Lecture for the Nobel Prize for Physiology or Medicine, 1980: Studies in histocompatibility. , 1992, Scandinavian journal of immunology.

[41]  R. Gale,et al.  Graft versus leukemia , 1992, Immunologic research.

[42]  J. Meyers,et al.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.

[43]  A. Rimm,et al.  T-cell depletion of HLA-identical transplants in leukemia. , 1991, Blood.

[44]  J. Niland,et al.  A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .

[45]  A. Rimm,et al.  Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.

[46]  H. Broxmeyer,et al.  Transplantation of umbilical cord blood in Fanconi's anemia. , 1990, Nouvelle revue francaise d'hematologie.

[47]  W. Wilmanns,et al.  Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. , 1990, Blood.

[48]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[49]  M. Pepe,et al.  Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. , 1989, Blood.

[50]  J. Natvig,et al.  The Noble Lectures in Immunology , 1989 .

[51]  R Storb,et al.  Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. , 1989, Blood.

[52]  H. Broxmeyer,et al.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Santos.  Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation. , 1989, Bone marrow transplantation.

[54]  R. Storb,et al.  What radiation dose for DLA-identical canine marrow grafts? [published erratum appears in Blood 1989 Feb;73(2):624] , 1988 .

[55]  H. Deeg,et al.  Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity. , 1988, International journal of radiation oncology, biology, physics.

[56]  H. Deeg,et al.  Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. , 1988, Bone marrow transplantation.

[57]  R. Hoffmann,et al.  Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .

[58]  L. To,et al.  Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. , 1988, Transplantation proceedings.

[59]  B. Sandmaier,et al.  What radiation dose for DLA-identical canine marrow grafts? , 1988, Blood.

[60]  H. Deeg,et al.  Mechanisms of tolerance in canine radiation chimeras. , 1987, Transplantation proceedings.

[61]  H. Deeg,et al.  JOINT REPORT OF THE THIRD INTERNATIONAL WORKSHOP ON CANINE IMMUNOGENETICS: II. ANALYSIS OF THE SEROLOGICAL TYPING OF CELLS , 1987, Transplantation.

[62]  H. Deeg,et al.  FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.

[63]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[64]  H. Deeg,et al.  Joint report of the Third International Workshop on Canine Immunogenetics. I. Analysis of homozygous typing cells. , 1986, Transplantation.

[65]  R. Storb,et al.  Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience , 1985, Immunological reviews.

[66]  H. Deeg,et al.  Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts , 1985 .

[67]  G. Janossy,et al.  DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS , 1984, The Lancet.

[68]  H. Deeg,et al.  COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE AND METHOTREXATE IN DOGS GIVEN BONE MARROW GRAFTS FROM DLA‐HAPLOIDENTICAL LITTERMATES , 1984, Transplantation.

[69]  D. Catovsky,et al.  MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.

[70]  P. Neiman,et al.  TREATMENT OF CHRONIC GRANULOCYTIC LEUKAEMIA IN CHRONIC PHASE BY ALLOGENEIC MARROW TRANSPLANTATION , 1982, The Lancet.

[71]  H. Deeg,et al.  CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.

[72]  Kristine,et al.  Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. , 1982, Blood.

[73]  R. Good,et al.  TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLS , 1981, The Lancet.

[74]  K. Sullivan,et al.  Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. , 1981, The New England journal of medicine.

[75]  H. Deeg,et al.  In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance. , 1980, Journal of immunology.

[76]  B. Netzel,et al.  Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses. , 1980, Experimental hematology.

[77]  W. Ross,et al.  Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): long-term allogeneic engraftment without GVH-reaction. , 1979, Experimental hematology.

[78]  R. Storb,et al.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. , 1979, The New England journal of medicine.

[79]  R. Storb,et al.  Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. , 1979, The New England journal of medicine.

[80]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.

[81]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[82]  R. Storb,et al.  Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. , 1977, The Journal of clinical investigation.

[83]  R. Storb,et al.  Marrow grafts between unrelated dogs homozygous and identical for DLA antigens. , 1977, Transplantation proceedings.

[84]  P. Neiman,et al.  Cure of leukemia by marrow transplantation , 1977 .

[85]  D. Waber,et al.  AMITRIPTYLINE THERAPY IN PATIENTS WITH ANOREXIA NERVOSA , 1976, The Lancet.

[86]  R. Storb,et al.  Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. , 1976, Journal of immunology.

[87]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[88]  J. Rolland,et al.  Letter: diogenes syndrome. , 1975, Lancet.

[89]  R. Storb,et al.  Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state? , 1975, Journal of immunology.

[90]  F. Mooney.  COAL WORKER'S PNEUMOCONIOSIS AND CARCINOMA OF THE LUNG , 1975, The Lancet.

[91]  A. Rimm,et al.  GRAFT VERSUS LEUKEMIA: III. Apparent Independent Antihost and Antileukemic Activity of Transplanted Immunocompetent Cells , 1973 .

[92]  R. Storb,et al.  MARROW GRAFTS BETWEEN DL‐A‐MATCHED CANINE LITTERMATES , 1973, Transplantation.

[93]  H. Gralnick,et al.  BONE MARROW TRANSPLANTATION FROM HL‐A‐MATCHED DONORS TO PATIENTS WITH ACUTE LEUKEMIA TOXICITY AND ANTILEUKEMIC EFFECT , 1972, Transplantation.

[94]  P. Neiman,et al.  Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. , 1971, Blood.

[95]  R. Storb,et al.  Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture. , 1971, The Journal of clinical investigation.

[96]  R. Slavin,et al.  Marrow transplanation in man following cyclophosphamide. , 1971, Transplantation proceedings.

[97]  R. Storb,et al.  Cyclophosphamide regimens in rhesus monkey with and without marrow infusion. , 1970, Cancer research.

[98]  D. Chisholm,et al.  Serum Gastrin in Patients with Peptic Ulceration , 1970, British medical journal.

[99]  M. Bortin.  A COMPENDIUM OF REPORTED HUMAN BONE MARROW TRANSPLANTS , 1970, Transplantation.

[100]  R. Storb,et al.  METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTS , 1970, Transplantation.

[101]  R. Storb,et al.  Marrow infusions in dogs given midlethal or lethal irradiation. , 1970, Radiation research.

[102]  R. Storb,et al.  Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide. , 1969, Cancer research.

[103]  R. Storb,et al.  ALLOGENEIC CANINE BONE MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE , 1969, Transplantation.

[104]  Owens Ah,et al.  Allogeneic marrow transplants in cyclophosphamide treated mice. , 1969 .

[105]  A. Owens,et al.  Allogeneic marrow transplants in cyclophosphamide treated mice. , 1969, Transplantation proceedings.

[106]  R. Storb,et al.  MARROW GRAFTS BY COMBINED MARROW AND LEUKOCYTE INFUSIONS IN UNRELATED DOGS SELECTED BY HISTOCOMPATIBILITY TYPING , 1968, Transplantation.

[107]  R. Storb,et al.  CYTOTOXIC TYPING ANTISERA FOR MARROW GRAFTING IN LITTERMATE DOGS , 1968, Transplantation.

[108]  R. Storb,et al.  Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs , 2005 .

[109]  G. Gowland,et al.  Immunological Reactivity of Lymphoid Cells after Treatment with Anti-lymphocytic Serum , 1967, Nature.

[110]  M. Woodruff.  Transplantation of tissues and organs , 1967 .

[111]  R. Wilson,et al.  Activity of lymphoid tissues from antilymphocyte-serum-treated mice. , 1967, Lancet.

[112]  A. Motulsky,et al.  Treatment of hereditary spherocytosis in Peromyscus by radiation and allogeneic bone marrow transplantation. , 1967, Blood.

[113]  J. Bryant,et al.  Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. , 1966, Blood.

[114]  C. Symons,et al.  Measurement of A.D.P.-induced platelet aggregation and A.D.P.-splitting enzymes in plasma. , 1966, Lancet.

[115]  G. Mathé,et al.  Adoptive immunotherapy of acute leukemia: experimental and clinical results. , 1965, Cancer research.

[116]  R. Schwartz,et al.  Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder , 1965, Science.

[117]  T. Malinin,et al.  PERIPHERAL LEUKOCYTE INFUSION INTO LETHALLY IRRADIATED GUINEA PIGS. , 1965, Blood.

[118]  J. Andrews.  DOSE-TIME RELATIONSHIPS IN CANCER RADIOTHERAPY. A CLINICAL RADIOBIOLOGY STUDY OF EXTREMES OF DOSE AND TIME. , 1965, The American journal of roentgenology, radium therapy, and nuclear medicine.

[119]  E. Thomas,et al.  THE RECOVERY OF LETHALLY IRRADIATED DOGS GIVEN INFUSIONS OF AUTOLOGOUS LEUKOCYTES PRESERVED AT -80 C. , 1964, Blood.

[120]  Jacques F. Miller,et al.  Immunity and the thymus. , 1963 .

[121]  A. Levy,et al.  Prevention of Delayed Foreign Marrow Reaction in Lethally Irradiated Mice by Early Administration of Methotrexate , 1962, Nature.

[122]  E. Thomas,et al.  Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethylsulphoxide. , 1962, Blood.

[123]  A. Dalmasso,et al.  THE ROLE OF THE THYMUS IN DEVELOPMENT OF IMMUNOLOGIC CAPACITY IN RABBITS AND MICE , 1962, The Journal of experimental medicine.

[124]  J. Collins,et al.  Marrow transplants in lethally irradiated dogs given methotrexate. , 1962, Blood.

[125]  G. Andrews.  Criticality accidents in Vinca, Yugoslavia, and Oak Ridge, Tennessee. Comparison of radiation injuries and results of therapy. , 1962, JAMA.

[126]  D. Parkin,et al.  Prolonged Survival of a Bone-marrow Graft Resulting in a Blood-group Chimera* , 1960, British medical journal.

[127]  E. Thomas,et al.  Autografts of bone marrow in dogs after lethal total-body radiation. , 1960, Blood.

[128]  J. Cannon,et al.  Supralethal whole body irradiation and isologous marrow transplantation in man. , 1959, The Journal of clinical investigation.

[129]  R. Billingham,et al.  Quantitative studies on tissue transplantation immunity IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease , 1959, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[130]  E. Thomas,et al.  Homografts of bone marrow in dogs after lethal total-body radiation. , 1959, Blood.

[131]  P. Russell,et al.  Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. , 1959, The New England journal of medicine.

[132]  D. Uphoff.  Alteration of Homograft Reaction by A-methopterin in Lethally Irradiated Mice Treated with Homologous Marrow , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[133]  E. Thomas,et al.  Successful marrow homograft in the dog after radiation. , 1958, Surgery.

[134]  E. Thomas,et al.  Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. , 1957, The New England journal of medicine.

[135]  D. Uphoff.  Genetic factors influencing irradiation protection by bone marrow. I. The F1 hybrid effect. , 1957, Journal of the National Cancer Institute.

[136]  J. Loutit,et al.  Treatment of Murine Leukaemia with X Rays and Homologous Bone Marrow , 1956, British medical journal.

[137]  J. Trentin.  Mortality and Skin Transplantability in X-Irradiated Mice Receiving Isologous, Homologous or Heterologous Bone Marrow.∗ † , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[138]  L. Peer.  The Transplantation of Tissues , 1956 .

[139]  C. E. Ford,et al.  Cytological Identification of Radiation-Chimæras , 1956, Nature.

[140]  P. Nowell,et al.  Growth and continued function of rat marrow cells in x-radiated mice. , 1956, Cancer research.

[141]  D. W. V. Bekkum,et al.  Homo et hétérogreffe de tissus hématopoïétiques chez la souris , 1956 .

[142]  D. V. van Bekkum,et al.  Evidence for the cellular hypothesis in radiation protection by bone marrow cells. , 1956, Acta physiologica et pharmacologica Neerlandica.

[143]  R. Prehn,et al.  Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. , 1955, Journal of the National Cancer Institute.

[144]  E. Shelton,et al.  Modification of irradiation injury in mice and guinea pigs by bone marrow injections. , 1951, Journal of the National Cancer Institute.

[145]  L. Jacobson,et al.  EFFECT OF SPLEEN PROTECTION ON MORTALITY FOLLOWING X-IRRADIATION , 1949 .